| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 433 | 347 | +24.9% |
| EBITDA | 65.5 | 55.7 | +17.5% |
| EBITDA margin | 15.1% | 16.1% | −0.9 pts |
| Profit before tax | 55.1 | 41.8 | +31.7% |
| Net profit | 39.6 | 32.2 | +23.0% |
| EPS | ₹5.89 | ₹4.79 | +23.0% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 3,890 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 8.1 | 8.1 | 2.8 | 3.6 | 2.1 | ||
| 5.4 | 5.4 | 0.0 | — | — | ||
| 527 | 527 | 342 | 315 | 379 | ||
| 4,414 | — | — | — | — | ||
| 1,696 | 1,610 | 1,447 | 1,213 | 1,391 | ||
| — | +11.3% | +19.3% | −12.8% | — | ||
| 262 | 252 | 228 | 202 | 230 | ||
| 15.5% | 15.7% | 15.8% | 16.6% | 16.5% | ||
| 220 | 211 | 190 | 168 | 204 | ||
| 150 | 142 | 127 | 101 | 137 | ||
| 8.8% | 8.8% | 8.8% | 8.3% | 9.8% | ||
| ₹22.24 | ₹21.13 | ₹18.81 | ₹15.02 | ₹20.29 | ||
| — | +12.3% | +25.3% | −26.0% | — | ||
| — | 127 | 90.2 | 67.5 | 134 | ||
| — | −257 | −87.9 | −120 | −117 | ||
| −130 | −130 | 2.4 | −52.8 | 16.9 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 3,889.8 | |
| - Cash, Equiv & ST Investments | 2.1 | 3.6 | 2.8 | 8.1 | 8.1 | |
| + Minority Interest | — | — | 0.0 | 5.4 | 5.4 | |
| + Total Debt | 378.5 | 315.3 | 342.3 | 527.2 | 527.2 | |
| Enterprise Value | — | — | — | — | 4,414.4 | |
| Revenue | 1,391.0 | 1,212.6 | 1,446.6 | 1,609.7 | 1,696.2 | |
| Growth %, YoY | — | -12.8 | +19.3 | +11.3 | — | |
| EBITDA | 230.1 | 201.6 | 228.4 | 252.4 | 262.1 | |
| Margin % | 16.54 | 16.62 | 15.79 | 15.68 | 15.45 | |
| EBIT | 203.6 | 168.0 | 190.2 | 211.1 | 219.7 | |
| Net Income | 136.6 | 101.1 | 126.6 | 142.3 | 149.7 | |
| Margin % | 9.82 | 8.34 | 8.75 | 8.84 | 8.83 | |
| EPS, Adj (current shares) | 20.29 | 15.02 | 18.81 | 21.13 | 22.24 | |
| Growth %, YoY | — | -26.0 | +25.3 | +12.3 | — | |
| Cash from Operations | 134.3 | 67.5 | 90.2 | 127.1 | — | |
| Capital Expenditures | -117.4 | -120.3 | -87.9 | -257.2 | — | |
| Free Cash Flow | 16.9 | -52.8 | 2.4 | -130.1 | -130.1 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Vishnu Chemicals (NSE: VISHNU) had a market capitalisation of ₹3,650 crore at the 30 October 2026 close (₹542.15 a share), a PE ratio of 24.4 on the last four quarters' profit and a price-to-book ratio of 3.41. In FY26 its consolidated net profit was ₹142 crore on revenue of ₹1,610 crore; in Q1 FY27 (April–June 2026) it was ₹39.6 crore, up 23.0% year on year. Its debt-to-equity ratio was 0.49 on 31 March 2026. Promoters held 69.21% of the shares on 30 September 2026.
Vishnu Chemicals' PE ratio is 24.4 at the 30 October 2026 close (₹542.15 a share): a market capitalisation of ₹3,650 crore divided by consolidated net profit of ₹150 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹142 crore) it is 25.7.
Vishnu Chemicals' debt-to-equity ratio was 0.49 on 31 March 2026: borrowings of ₹527 crore against total equity of ₹1,075 crore. A year earlier, on 31 March 2025, it was 0.37.
Vishnu Chemicals' net worth — shareholders' equity in its consolidated balance sheet — was ₹1,069 crore on 31 March 2026, up 15.4% from ₹927 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹3,650 crore at the 30 October 2026 close.
Vishnu Chemicals' price-to-book (PB) ratio is 3.41 at the 30 October 2026 close: a market capitalisation of ₹3,650 crore divided by shareholders' equity (book value) of ₹1,069 crore on 31 March 2026. That is a book value of ₹158.83 per share against a share price of ₹542.15.
In FY26, Vishnu Chemicals' return on equity (ROE) was 14.3% and its return on capital employed (ROCE) was 16.3%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 15.6% and ROCE 18.6%.
Vishnu Chemicals' book value per share was ₹158.83 on 31 March 2026: shareholders' equity of ₹1,069 crore divided by the 6.73 crore shares in issue, up 15.4% from ₹137.67 a year earlier. The share price at the 30 October 2026 close was ₹542.15.
Vishnu Chemicals' market capitalisation was ₹3,650 crore at the 30 October 2026 close: 6.73 crore shares at ₹542.15 each.
Vishnu Chemicals' basic earnings per share (EPS) were ₹21.14 in FY26, against ₹19.23 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹22.28.
In 2026, Vishnu Chemicals has declared one dividend: ₹0.30 with record date 21 August 2026.
No. Vishnu Chemicals had borrowings of ₹527 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.49. Its cash and current investments were ₹100 crore, so its net debt was ₹427 crore.
Promoters held 69.21% of Vishnu Chemicals on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
Vishnu Chemicals will announce its Q2 FY27 results (July–September 2026) on Saturday, 31 October 2026, the date of the board meeting it has notified to the exchanges.
Vishnu Chemicals' dividend yield is 0.06% at the 30 October 2026 close: dividends of ₹0.30 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹542.15. They were ₹0.30 on 21 August 2026.
In FY26, Vishnu Chemicals generated ₹127 crore of cash from operations and spent ₹257 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹130 crore. In FY25 it was ₹2.4 crore.
Vishnu Chemicals' latest results are for Q1 FY27 (April–June 2026), filed on 1 August 2026: consolidated net profit ₹39.6 crore, up 23.0% from ₹32.2 crore in Q1 FY26; revenue from operations ₹433 crore, up 24.9% year on year.
On 30 September 2026, Vishnu Chemicals' shares were held by promoters 69.21%, foreign portfolio investors (FII/FPI) 2.54%, domestic institutions (DII) 5.85% (including mutual funds at 4.58%) and retail and other non-institutional investors 22.40%. Over the year, FII holding was up 0.30 percentage points from 2.24% and DII holding was up 0.26 percentage points from 5.59%.
In FY26 (April 2025–March 2026), Vishnu Chemicals' consolidated net profit was ₹142 crore, up 12.3% from ₹127 crore in FY25, on revenue from operations of ₹1,610 crore (up 11.3%). Over three years, from FY23, net profit was up 4.2%.
In FY26, Vishnu Chemicals earned net profit of ₹142 crore on revenue of ₹1,610 crore, against ₹42.1 crore on ₹506 crore for Tatva Chintan Pharma Chem. Vishnu Chemicals' operating margin was 13.1% (Tatva Chintan Pharma Chem 11.1%) and its return on equity 14.3% (Tatva Chintan Pharma Chem 5.5%). At the 30 October 2026 close, Vishnu Chemicals' market capitalisation was ₹3,650 crore against ₹3,845 crore for Tatva Chintan Pharma Chem, and its PE ratio on FY26 profit 25.7 against 91.4.
On FY26 consolidated figures, against Tatva Chintan Pharma Chem and Gujarat Alkalies and Chemicals: Vishnu Chemicals' operating margin of 13.1% is the highest of the three (Tatva Chintan Pharma Chem 11.1%, Gujarat Alkalies and Chemicals −0.2%; peer average 5.5%); its return on equity of 14.3% is the highest of the three (Tatva Chintan Pharma Chem 5.5%, Gujarat Alkalies and Chemicals −0.0%; peer average 2.7%); its revenue growth over three years of 5.0% a year is the second highest of the three (Tatva Chintan Pharma Chem 6.1% a year, Gujarat Alkalies and Chemicals −1.2% a year; peer average 2.5% a year).
From Vishnu Chemicals' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.